Bivalirudin vs Heparin in ECMO Patients

Withdrawn before enrolling · Phase 1

Conditions studied: Extracorporeal Membrane Oxygenation Complication

In brief

This is an open label, randomized study comparing the clinical outcomes of unfractionated Heparin and Bivalirudin for anticoagulation in adult subjects requiring ECMO support.

Key facts

Study ID

NCT03707418

Run by

Johns Hopkins University

People needed

0

Starts

2021-04-01

Expected to finish

2021-06-01

Last updated by the study team

2021-01-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients on veno-arterial (VA) or veno-venous (VV)ECMO

You may not qualify if…

• Patient or surrogate decision makers cannot provide informed consent.
• Patients who have intolerance to either heparin or bivalirudin
• Patients who received any form of thrombolytic therapy within the past 30 days.

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.